Search Medical Condition
Please enter condition
Please choose location

Ciudad Real, Spain Clinical Trials

A listing of Ciudad Real, Spain clinical trials actively recruiting patients volunteers.

RESULTS

Found (30) clinical trials

PROSTAC: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Docetaxel or Cabazitaxel

Observational study to analyze prognostic factors in castration resistant prostate cancer patients.

Phase N/A

103.77 miles

Learn More »

Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer

The hypothesis that arises is an improvement in the proportion of pathological complete responses, resulting therapeutic gain, as a result of a higher dose of radiation delivered to the tumor volume without incurring a higher gastrointestinal toxicity to the patient or surgical complications later, thanks to the use of intensity ...

Phase

90.43 miles

Learn More »

Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP)

Multicenter randomized trial centered on critically-ill tracheostomized patients, comparing two different decannulation protocols: based on capping trials to decide decannulation, based on the aspiration frequency to decide decannulation time. High-flow conditioned oxygen therapy will be applied to all patients through the tracheal cannula. In patients included in the suctioning frequency ...

Phase N/A

60.9 miles

Learn More »

Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.

The purpose of this study is to show if prolonging treatment with temozolomide to 12 cycles improve progression-free survival in patients with glioblastoma included in this study, randomized according to o6-methylguanine-DNA-methyltransferase (MGMT) methylation status and residual disease or not, to receive an additional 6 cycles of temozolomide.

Phase

94.89 miles

Learn More »

PROSABI: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Abiraterone

Prospective Multi-centre Studies of Prognostic Factors in Castration resistant PROState Cancer Treated With Abiraterone (PROSABI)

Phase N/A

98.69 miles

Learn More »

Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

The purpose of this study is to evaluate, in terms of overall survival, the benefit of monoclonal antibodies in the start time of the diagnosis of advanced disease or administer a deferred basis after progression to treatment with chemotherapy alone.

Phase N/A

131.62 miles

Learn More »

Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol

Study data Data will be collected on all eligible patients who undergo elective lower gastrointestinal surgery within any compliance of an ERAS protocol during the study months. Only routine clinical data will be included and where this is unavailable the domain will be left blank e.g. patients who do not ...

Phase N/A

60.9 miles

Learn More »

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

The purpose of study is to test whether rivaroxaban added to standard of care treatment, when compared to placebo, has the potential to reduce the incidence of the clinical events related to the clots and complications of the heart and brain (CV death, MI, or stroke) or the legs (acute ...

Phase

125.4 miles

Learn More »

Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues

The intention of this study is to investigate how many patients with prostate cancer, planned to be treated with LHRH analogues without history of surgery or radiotherapy, are suffering from LUTS. In addition the effect of LHRH analogues on the improvement of theses primary LUTS symptoms over time will be ...

Phase N/A

90.97 miles

Learn More »

Prospective Single-arm Multi Centre Observations Ultimaster Des Registry

All consecutive patients suitable for treatment with DES according to hospital routine practice in centres across the world that agree to participate in the e-ULTIMASTER registry will be treated with Ultimaster DES. Secondary objectives Evaluation of worldwide utilization of DES, Detection of rare events in representative patient population, identification of ...

Phase N/A

60.9 miles

Learn More »